Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3249]

NCCN working with Medlive to advance high-quality cancer care in China and worldwide

NCCN working with Medlive to advance high-quality cancer care in China and worldwide

Zanubrutinib receives European commission approval for the treatment of adults with marginal zone lymphoma

Zanubrutinib receives European commission approval for the treatment of adults with marginal zone lymphoma

How ‘chameleon cancers’ can change their colors to survive treatment

How ‘chameleon cancers’ can change their colors to survive treatment

Advanced nanoparticles provide new weapon to fight difficult cancers

Advanced nanoparticles provide new weapon to fight difficult cancers

Scientists pinpoint druggable target in aggressive breast cancer

Scientists pinpoint druggable target in aggressive breast cancer

$FDA approves teclistamab-cqyv for relapsed or refractory multiple myeloma$

FDA approves teclistamab-cqyv for relapsed or refractory multiple myeloma

Liquid biopsies can detect which cancer patients may be at higher risk of developing additional blood cancers

Liquid biopsies can detect which cancer patients may be at higher risk of developing additional blood cancers

Gene mutations in tumours impact radiation sensitivity

Gene mutations in tumours impact radiation sensitivity

Low blood phosphate levels may be linked to neurological side effects from CAR T-cell therapy

Low blood phosphate levels may be linked to neurological side effects from CAR T-cell therapy

WCC 2022: The Medicines Patent Pool signs licence agreement to increase access to nilotinib for the treatment of chronic myeloid leukaemia

WCC 2022: The Medicines Patent Pool signs licence agreement to increase access to nilotinib for the treatment of...

More from ecancer